Učitavanje...

Lower cognitive performance in healthy G2019S LRRK2 mutation carriers

OBJECTIVE: To assess cognitive abilities of healthy first-degree relatives of Ashkenazi patients with Parkinson disease (PD), carriers of the G2019S mutation in the LRRK2 gene. METHODS: In this observational study, 60 consecutive healthy first-degree relatives (aged 50.9 ± 6.2 years; 48% male; 30 G2...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Thaler, Avner, Mirelman, Anat, Gurevich, Tanya, Simon, Ely, Orr-Urtreger, Avi, Marder, Karen, Bressman, Susan, Giladi, Nir
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3430708/
https://ncbi.nlm.nih.gov/pubmed/22914834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182684646
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!